MGC Diagnostics (MGCD) Reports Q3 EPS of $0.80

MGC Diagnostics (NASDAQ: MGCD) reported Q3 EPS of $0.80, versus ($0.21) reported last year. Revenue for the quarter came in at $9.24 million, versus $6.6 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
• Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c